Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Doctor Compares Wegovy Injections to New Weight Loss Pill - Featured image
GLP-1 Medications

Doctor Compares Wegovy Injections to New Weight Loss Pill

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·January 15, 2026·2 min read

On this page

  • Dr. Drew Payne on Key Differences
  • Consistent Weight Loss Results
  • Significant Cost Savings
  • Prescription Requirements and Switching

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

The new FDA-approved Wegovy pill offers the same weight loss benefits as injections but in a daily oral dose. Dr. Drew Payne explains why higher doses are needed due to GI absorption and how both achieve 15% average weight loss. Costs drop significantly, making treatment more affordable.

Share

On this page

  • Dr. Drew Payne on Key Differences
  • Consistent Weight Loss Results
  • Significant Cost Savings
  • Prescription Requirements and Switching

Weight loss medication Wegovy is now available in pill form, delivering the same active ingredient, semaglutide, as the weekly injections but as a daily oral dose. This option could improve accessibility and affordability for obesity treatment.

Dr. Drew Payne on Key Differences

The FDA-approved pill contains the same medicine as Wegovy injections, but it requires higher dosages because absorption in the gastrointestinal tract is lower, explained Dr. Drew Payne, D.O., an internist at Texas Tech Health Sciences Center specializing in obesity.

"The ingredient in the pill or the active medicine in the pill is the same as the injection," Payne said. "The only real kind of difference is the medicine isn't absorbed as well in the GI tract so the dosage is quite a bit higher."

Consistent Weight Loss Results

At maximum doses, both the pill and injection versions help patients lose about 15% of their body weight on average, according to Payne. Side effects are also similar between the two forms.

Patient Pam Simpson lost 55 pounds using the injection and called it "one of the best decisions I've ever made." Diane Harlan lost 105 pounds, reducing her blood pressure medication needs, and said, "I think it's a miracle... It was the easiest thing I've ever done."

Significant Cost Savings

The pill version costs much less than injections. Wegovy pricing starts at $149 per month, with the highest doses under $400, compared to over $1,000 monthly for some injection users.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

"The cost will be less because it's less to manufacture," Payne said. "You don't have the auto-injector cost built into it."

Prescription Requirements and Switching

A prescription is still required for the pill. Patients can order it directly from the manufacturer's website with a physician's approval, and local pharmacies will soon stock it.

  • Approved for patients age 12 and older
  • Current injection users can switch to the pill
  • Apps like Shotlee help track daily GLP-1 doses for consistency

"You can switch from an injection to a pill," Payne said. Simpson prefers sticking with injections: "I don't like the idea of taking a pill every day."

The drug does not work for everyone, and rare serious side effects are possible, necessitating doctor monitoring via prescription.

Source Information

Originally published by https://www.kcbd.com.Read the original article →

Read next

Keep exploring

More on Wegovy

Articles covering Wegovy dosing, side effects, and clinical updates.

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read

Same topic: Wegovy

All Wegovy articles →
Wegovy Side Effects: Black Tongue, Pain, Gallbladder Removal in Woman's Story
GLP-1 Medications

Wegovy Side Effects: Black Tongue, Pain, Gallbladder Removal in Woman's Story

A 32-year-old bride-to-be turned to Wegovy for wedding weight loss, only to face black tongue, unbearable stomach pain, and gallbladder removal. Sarah-Jayne Crawford's ordeal highlights hidden dangers of semaglutide injections. Despite initial success, severe side effects led to emergency surgery.

6 min read
EU Approves Easier Wegovy Delivery, Easing Cold Chain Rules
GLP-1 Medications

EU Approves Easier Wegovy Delivery, Easing Cold Chain Rules

Novo Nordisk has won EU regulatory approval to ease cold chain requirements for Wegovy injections, marking the first GLP-1 therapy in Europe with such delivery flexibility. The change allows a 48-hour window without refrigeration from pharmacies to patients, streamlining distribution and enhancing access. This aligns with trends in direct-to-patient models and complements recent subscription programs for better affordability.

5 min read
Doctor Warns of 'Miserable' Constipation from Wegovy as NHS Expands to 1.2M
GLP-1 Medications & Side Effects

Doctor Warns of 'Miserable' Constipation from Wegovy as NHS Expands to 1.2M

The NHS has expanded free Wegovy access to 1.2 million more people, but a doctor is urging caution over a 'miserable' side effect: constipation. Dr. Suraj Kukadia explains how GLP-1 medications like Wegovy slow digestion, leading to this common issue. Discover the mechanism and tips for those considering these weight loss jabs.

5 min read

More in GLP-1 Medications

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39
Health & Wellness

Wegovy, Zepbound & More: Hers Makes GLP-1s Accessible from $39

The journey to weight loss can be challenging, and for many, advanced medications like GLP-1 injectables offer a crucial pathway. However, their high cost often presents a significant barrier. Hers is changing this landscape by making popular GLP-1 and other weight loss treatments more accessible and affordable than ever before.

7 min read
Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise
Medical News

Retatrutide Phase 3 Results: 28% Weight Loss and the Triple Agonist Promise

Eli Lilly has released pivotal Phase 3 trial data for retatrutide, a triple agonist showing up to 28% body weight reduction and significant improvements in diabetes and sleep apnea.

7 min read
Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym
Medical Insights

Beyond GLP-1s: Unlocking Better Diabetes Control with Korlym

For individuals struggling with difficult-to-control type 2 diabetes and weight management, even powerful GLP-1 medications might not be enough. New research highlights the significant role of hypercortisolism and the promising potential of Korlym in optimizing treatment outcomes.

6 min read
Share this article
  1. Home
  2. Blog
  3. Doctor Compares Wegovy Injections to New Weight Loss Pill
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community